Scientists uncover genetic link to ME/chronic fatigue syndrome

The world’s largest investigation into the genetics of ME/CFS, led by the DecodeME project at the University of Edinburgh, analysed DNA samples from more than 27,000 patients and compared them with over 250,000 healthy participants. Researchers found eight regions of the genome with clear differences in those diagnosed with ME/CFS.
The findings suggest that common genetic variations many linked to the immune system and nervous system could tip the balance toward the illness, which is estimated to affect 67 million people globally.
Prof Chris Ponting, a lead investigator on the study, called the results “a wake-up call”, adding:“These findings provide the first robust evidence for genetic contributions to ME. They show that people’s biology really does matter when it comes to this condition.”
Patient groups hailed the research as a milestone moment. Sonya Chowdhury, chief executive of Action for ME, said the discovery brought “validity and credibility” to millions of people who have long been disbelieved or told their illness was not real.
ME/CFS symptoms include extreme fatigue, brain fog, chronic pain, sleep disturbances, and post-exertional malaise, where even light activity can cause prolonged relapses. There is currently no diagnostic test and no cure.
The DecodeME team hopes the findings will pave the way for future treatments and better recognition of a disease that costs the UK economy more than £3bn each year.
While the genetic evidence sheds light on possible mechanisms, questions remain. Researchers are still investigating why women are disproportionately affected, and how the condition relates if at all to long Covid.
For patients, the discovery represents progress after decades of frustration. “This doesn’t give us a cure,” said Andy Devereux-Cooke, a patient researcher on the project, “but it gives us hope and that is huge.”